Scientists turn to medical imaging for deep analysis of John Constable painting

Scientists at the University of Bradford in England utilized medical imaging to analyze a painting believed to be by 19th-century artist John Constable. 

Conducted on a privately owned piece to confirm its authenticity, the 19th-century oil painting underwent a series of non-destructive tests, including a CT scan, Raman spectroscopy, 3D microscopy and an X-ray, all to identify its chemical composition and any layers of paint. 

The painting exhibited pigments typical of Constable's palette, and there seemed to be evidence of multiple layers, which is consistent with Constable's characteristic technique of "overwork," wherein the painting is re-worked at different times. However, the investigative process—which took several weeks—will take months of data analysis to confirm any findings. The results will then be presented to Constable experts for review.

Determining the actual painter behind a piece cannot be definitely confirmed through any analysis, but with enough evidence showing consistency with an artist’s other works, experts can make an educated determination. Regardless, the combination of techniques used for this analysis is largely unprecedented and could mark the most precise scientific study of a painting to date, according to coverage in the Yorkshire Post

John Constable was renowned for his landscapes of the English countryside. He passed away in 1837, and his work is extremely valuable to collectors and historians alike. 

Read the full feature from the Yorkshire Post at the link below.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.